Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Arthur Kuan currently holds 198,916 shares of CG Oncology, Inc. (CGON), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Arthur Kuan has been a net neutral trader of CGON stock. They have purchased $0 and sold $0 worth of shares.
Arthur Kuan's most recent insider trade was on Mar 12, 2026, when they sold 64,612 shares at $0.00 per share.
Arthur Kuan serves as Executive at CG Oncology, Inc. (CGON). They have executed 7 insider transactions totaling $0 over their tenure at the company.
Arthur Kuan holds the position of Executive at CG Oncology, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Arthur Kuan has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Arthur Kuan was on Mar 4, 2026, when they sold $176.9K worth of CGON shares. This transaction involved 102,871 shares at $1.72 per share.
Arthur Kuan currently owns 198,916 shares of CG Oncology, Inc. (CGON), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Arthur Kuan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Arthur Kuan has 7 Form 4 filings on record as an insider at CG Oncology, Inc..
Set alerts for Arthur Kuan and 40,000+ other insiders.